Related Experiment Video

Updated: Apr 18, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K

TAK1 selective inhibition: state of the art and future opportunities

Iain Kilty1, Lyn H Jones

  • 1Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA.

Future Medicinal Chemistry
|January 14, 2015
PubMed

Insights

Transforming growth factor-β-activated kinase 1 (TAK1) is a key regulator in inflammation and cancer. This review covers TAK1

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Drug Discovery

Background:

  • Mitogen-activated protein kinase kinase kinase (MAPKKK) TAK1 is a crucial signaling node.
  • TAK1 regulates inflammatory responses and cell death pathways.
  • TAK1 is implicated in inflammatory diseases and cancer.

Purpose of the Study:

  • Review the role of TAK1 in inflammation.
  • Summarize current small molecule inhibitor development for TAK1.
  • Explore chemical biology approaches for TAK1 targeting.

Main Methods:

  • Literature review of TAK1 inhibitors.
  • Analysis of TAK1 signaling pathways.
  • Discussion of therapeutic strategies.

Main Results:

  • TAK1 inhibitors targeting the active site cysteine have been developed.
  • ATP-competitive (type I) and DFG-out (type II) inhibitors are emerging.
  • Small molecule inhibitors show therapeutic potential.

Conclusions:

  • TAK1 is a promising therapeutic target for inflammatory conditions and cancer.
  • Diverse small molecule inhibitors are advancing TAK1-targeted therapies.
  • Chemical biology offers new avenues for TAK1 drug development.
Keywords:
DFG-outMAPKNFκBTAK1covalent inhibitorinflammationkinase

More Related Videos

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

18.0K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
12.0K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Patch Clamp01:18

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
7.7K